公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2014 | Quantification of target analytes in various biofluids using a postcolumn infused-internal standard method combined with matrix normalization factors in liquid chromatography-electrospray ionization mass spectrometry | Liao H.-W.; Tsai I.-L.; GUAN-YUAN CHEN ; YEN-SHEN LU ; CHING-HUNG LIN ; CHING-HUA KUO | Journal of Chromatography A | 12 | 12 | |
2012 | Radiosensitizing effect of a phenylbutyrate-derived histone deacetylase inhibitor in hepatocellular carcinoma | YEN-SHEN LU ; Chou C.-H.; KAI-YUAN TZEN ; Gao M.; ANN-LII CHENG ; Kulp S.K.; CHIA-HSIEN CHENG | International Journal of Radiation Oncology Biology Physics | 21 | 20 | |
2022 | A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer | Kuemmel S.; Campone M.; Loirat D.; Lopez R.L.; Thaddeus Beck J.; de Laurentiis M.; Im S.-A.; Kim S.-B.; Kwong A.; Steger G.G.; Adelantado E.Z.; Duhoux F.P.; Greil R.; Kuter I.; YEN-SHEN LU ; Tibau A.; ?zg?ro?lu M.; Scholz C.W.; Singer C.F.; Vega E.; Wimberger P.; Zamagni C.; Couillebault X.-M.; Fan L.; Guerreiro N.; Mataraza J.; Sand-Dejmek J.; Chan A. | Clinical Cancer Research | 15 | 15 | |
2004 | Recent advances in the management of primary breast cancers | YEN-SHEN LU ; SUNG-HSIN KUO ; CHIUN-SHENG HUANG | Journal of the Formosan Medical Association | 15 | 14 | |
2021 | Regulatory and operational challenges in conducting Asian International Academic Trial for expanding the indications of cancer drugs | Hata T.; Nakamura K.; Yonemori K.; Noguchi E.; Watanabe M.; Sohn J.; YEN-SHEN LU ; Yap Y.-S.; Tamura K.; Fujiwara Y. | Clinical and Translational Science | 2 | 1 | |
2020 | Response to Sung, Rosenberg, and Yang | CHING-HUNG LIN ; Yap Y.S.; Lee K.-H.; Yeo W.; Ueno T.; Li H.; Huang S.-M.; YEN-SHEN LU | Journal of the National Cancer Institute | 0 | 0 | |
2019 | Ribociclib and Endocrine Therapy in Breast Cancer. Reply | Im S.-A; YEN-SHEN LU ; Tripathy D. | The New England journal of medicine | 2 | 2 | |
2018 | Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial | Tripathy D; Im S.-A; Colleoni M; Franke F; Bardia A; Harbeck N; Hurvitz S.A; Chow L; Sohn J; Lee K.S; Campos-Gomez S; Villanueva Vazquez R; Jung K.H; Babu K.G; Wheatley-Price P; De Laurentiis M; Im Y.-H; Kuemmel S; El-Saghir N; Liu M.-C; Carlson G; Hughes G; Diaz-Padilla I; Germa C; Hirawat S; YEN-SHEN LU | The Lancet Oncology | 633 | 545 | |
2021 | Role of alpelisib in the treatment of pik3ca-mutated breast cancer: Patient selection and clinical perspectives | DWANG-YING CHANG ; WEI-LI MA ; YEN-SHEN LU | Therapeutics and Clinical Risk Management | 28 | 24 | |
2023 | Synergistic efficacy of telomerase-specific oncolytic adenoviral therapy and histone deacetylase inhibition in human hepatocellular carcinoma | ZHONG-ZHE LIN ; Hu, Mickey C-T; CHIUN HSU ; YAO-MING WU ; YEN-SHEN LU ; Ho, Ja-An Annie; Shiou-Hwei Yeh ; PEI-JER CHEN ; ANN-LII CHENG | Cancer letters | 1 | 1 | |
2020 | Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP regimen) significantly improves overall survival | WEI-WU CHEN ; I-SHIOW JAN ; DWANG-YING CHANG ; CHING-HUNG LIN ; I-CHUN CHEN ; Chen H.-M.; ANN-LII CHENG ; YEN-SHEN LU | Journal of Neuro-Oncology | 17 | 13 | |
2016 | Tailor the adjuvant hormonal manipulation for premenopausal breast cancer patients | WEI-WU CHEN ; CHING-HUNG LIN ; YEN-SHEN LU | Translational Cancer Research | 0 | 0 | |
2017 | Toxicity profile differences of adjuvant docetaxel/cyclophosphamide (TC) between Asian and Caucasian breast cancer patients | Chow L.W.C.; Biganzoli L.; Leo A.D.; Kuroi K.; Han H.S.; Patel J.; CHIUN-SHENG HUANG ; YEN-SHEN LU ; Zhu L.; Chow C.Y.C.; Loo W.T.Y.; Gl?ck S.; Toi M. | Asia-Pacific Journal of Clinical Oncology | 16 | 17 | |
2015 | TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays | CHING-HUNG LIN ; Chen I.-C.; CHIUN-SHENG HUANG ; Hu F.-C.; WEN-HUNG KUO ; KUAN-TING KUO ; Wang C.-C.; Wu P.-F.; DWANG-YING CHANG ; Wang M.-Y.; Chang C.-H.; WEI-WU CHEN ; YEN-SHEN LU ; ANN-LII CHENG | Scientific Reports | 10 | 11 | |
2023 | Transcriptomic alterations underlying metaplasia into specific metaplastic components in metaplastic breast carcinoma | HUANG-CHUN LIEN ; Hsu, Chia-Lang; YEN-SHEN LU ; WEI-WU CHEN ; I-CHUN CHEN ; Li, Yu-Chia; CHIUN-SHENG HUANG ; ANN-LII CHENG ; CHING-HUNG LIN | Breast cancer research : BCR | 0 | 0 | |
1996 | Transient ‘Milky Urine’ after Cardiac Catheterization: Another Unreported Cause of Non-Parasitic Chyluria | Chen H.-S.; Yen T.-S.; YEN-SHEN LU ; JYH-CHIN YANG ; Ko Y.-L. | Nephron | 9 | 8 | |
2019 | Treating HR+/HER2− breast cancer in premenopausal Asian women: Asian Breast Cancer Cooperative Group 2019 Consensus and position on ovarian suppression | Yeo W.; Ueno T.; CHING-HUNG LIN ; Liu Q.; Lee K.-H.; Leung R.; Naito Y.; Park Y.H.; Im S.-A.; Li H.; Yap Y.S.; YEN-SHEN LU ; The Asian Breast Cancer Cooperative Group | Breast Cancer Research and Treatment | 29 | 27 | |
2021 | Tumor-infiltrating lymphocyte abundance and programmed death-ligand 1 expression in metaplastic breast carcinoma: implications for distinct immune microenvironments in different metaplastic components | HUANG-CHUN LIEN ; Lee Y.-H.; I-CHUN CHEN ; CHING-HUNG LIN ; WEI-WU CHEN ; Lu Y.-T.; YEN-SHEN LU | Virchows Archiv | 15 | 13 | |
2010 | Unique features of breast cancer in Asian women-Breast cancer in Taiwan as an example | CHIUN-SHENG HUANG ; CHING-HUNG LIN ; YEN-SHEN LU ; Shen C.-Y. | Journal of Steroid Biochemistry and Molecular Biology | 42 | 44 | |
2022 | Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2- Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial | YEN-SHEN LU ; Im S.-A.; Colleoni M.; Franke F.; Bardia A.; Cardoso F.; Harbeck N.; Hurvitz S.; Chow L.; Sohn J.; Lee K.S.; Campos-Gomez S.; Vazquez R.V.; Jung K.H.; Babu K.G.; Wheatley-Price P.; De Laurentiis M.; Im Y.-H.; Kuemmel S.; El-Saghir N.; O'Regan R.; Gasch C.; Solovieff N.; Wang C.; Wang Y.; Chakravartty A.; Ji Y.; Tripathy D. | Clinical Cancer Research | 75 | 38 |